Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1119)
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
394
Price
$84.00
Total Value
$33.09K
Shares Held After
77,335
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
447
Price
$86.62
Total Value
$38.72K
Shares Held After
232,588
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,437
Price
$85.78
Total Value
$123.27K
Shares Held After
233,035
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
2,519
Price
$85.04
Total Value
$214.21K
Shares Held After
234,472
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
492
Price
$84.00
Total Value
$41.33K
Shares Held After
236,991
% of Holdings
0.2%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
184,208
Price
$14.22
Total Value
$2.62M
Shares Held After
12,229,500
% of Holdings
1.5%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
2,380
Price
$16.15
Total Value
$38.44K
Shares Held After
1,934,247
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
50,703
Price
$15.49
Total Value
$785.39K
Shares Held After
1,936,627
% of Holdings
2.6%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
3,367
Price
$2.08
Total Value
$7.01K
Shares Held After
107,465
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$509.20
Total Value
$25.46K
Shares Held After
170
% of Holdings
22.7%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
1,000
Price
$21.89
Total Value
$21.89K
Shares Held After
8,397
% of Holdings
11.9%
Crinetics Pharmaceuticals, Inc. (CRNX)
Schilke Tobin — Chief Financial Officer
Shares
6,713
Price
$39.67
Total Value
$266.30K
Shares Held After
78,121
% of Holdings
7.9%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
170,000
Price
$3.46
Total Value
$588.20K
Shares Held After
6,259,863
% of Holdings
2.6%
Crinetics Pharmaceuticals, Inc. (CRNX)
Okey Stephanie — Director
Shares
3,000
Price
$39.67
Total Value
$119.01K
Shares Held After
13,300
% of Holdings
18.4%
FibroBiologics, Inc. (FBLG)
O'HEERON PETE — Director
Shares
18,200
Price
$0.41
Total Value
$7.37K
Shares Held After
5,942,275
% of Holdings
0.3%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
1,649
Price
$22.06
Total Value
$36.38K
Shares Held After
37,482
% of Holdings
4.2%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
1,012
Price
$80.82
Total Value
$81.79K
Shares Held After
11,014
% of Holdings
8.4%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
6,794
Price
$80.00
Total Value
$543.49K
Shares Held After
12,026
% of Holdings
36.1%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
13,526
Price
$79.17
Total Value
$1.07M
Shares Held After
18,820
% of Holdings
41.8%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Washburn Theodore James Jr. — Principal Accounting Officer
Shares
5,272
Price
$28.88
Total Value
$152.26K
Shares Held After
868
% of Holdings
85.9%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
802
Price
$80.76
Total Value
$64.77K
Shares Held After
80,554
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
12,687
Price
$79.88
Total Value
$1.01M
Shares Held After
81,356
% of Holdings
13.5%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
71,600
Price
$79.10
Total Value
$5.66M
Shares Held After
94,043
% of Holdings
43.2%
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
1,005
Price
$80.80
Total Value
$81.20K
Shares Held After
3,811
% of Holdings
20.9%
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
14,608
Price
$79.88
Total Value
$1.17M
Shares Held After
4,816
% of Holdings
75.2%
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
39,265
Price
$79.11
Total Value
$3.11M
Shares Held After
19,424
% of Holdings
66.9%
Zai Lab Ltd (ZLAB)
Amado Rafael — President, Head of Global Oncology Research and Development
Shares
10,000
Price
$17.38
Total Value
$173.80K
Shares Held After
42,391
% of Holdings
19.1%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
36
Price
$81.01
Total Value
$2.92K
Shares Held After
4,347
% of Holdings
0.8%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
2,088
Price
$80.41
Total Value
$167.89K
Shares Held After
4,383
% of Holdings
32.3%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
4,096
Price
$79.36
Total Value
$325.06K
Shares Held After
41,317
% of Holdings
9.0%
IONIS PHARMACEUTICALS INC (IONS)
LOSCALZO JOSEPH — Director
Shares
832
Price
$80.33
Total Value
$66.83K
Shares Held After
36,330
% of Holdings
2.2%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
755
Price
$80.84
Total Value
$61.03K
Shares Held After
22,541
% of Holdings
3.2%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
5,030
Price
$80.00
Total Value
$402.39K
Shares Held After
23,296
% of Holdings
17.8%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
14,321
Price
$79.11
Total Value
$1.13M
Shares Held After
28,326
% of Holdings
33.6%
Editas Medicine, Inc. (EDIT)
Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Shares
749
Price
$2.02
Total Value
$1.51K
Shares Held After
68,028
% of Holdings
1.1%
Editas Medicine, Inc. (EDIT)
Parison Amy — SVP, Chief Financial Officer
Shares
474
Price
$2.02
Total Value
$957.48
Shares Held After
15,434
% of Holdings
3.0%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$29.76
Total Value
$60.53K
Shares Held After
235,626
% of Holdings
0.9%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
233
Price
$187.84
Total Value
$43.77K
Shares Held After
405,796
% of Holdings
0.1%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
2,608
Price
$186.73
Total Value
$487.00K
Shares Held After
406,029
% of Holdings
0.6%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
3,159
Price
$186.09
Total Value
$587.84K
Shares Held After
408,637
% of Holdings
0.8%
Editas Medicine, Inc. (EDIT)
O'Neill Gilmore Neil — Director
Shares
5,394
Price
$2.02
Total Value
$10.89K
Shares Held After
263,693
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
1,635
Price
$22.40
Total Value
$36.62K
Shares Held After
85,034
% of Holdings
1.9%
Olema Pharmaceuticals, Inc. (OLMA)
Mitchell Shawnte — CHIEF LEGAL OFFICER
Shares
15,000
Price
$23.01
Total Value
$345.15K
Shares Held After
0
% of Holdings
100.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,518
Price
$16.33
Total Value
$106.44K
Shares Held After
583,911
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
24,423
Price
$15.49
Total Value
$378.31K
Shares Held After
590,429
% of Holdings
4.0%
Adaptive Biotechnologies Corp (ADPT)
GRIFFIN MICHELLE RENEE — Director
Shares
48,044
Price
$15.30
Total Value
$735.07K
Shares Held After
15,394
% of Holdings
75.7%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
13,555
Price
$18.22
Total Value
$246.91K
Shares Held After
145,355
% of Holdings
8.5%
Bicara Therapeutics Inc. (BCAX)
Raben David — Chief Medical Officer
Shares
200
Price
$18.45
Total Value
$3.69K
Shares Held After
55,286
% of Holdings
0.4%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,500
Price
$18.16
Total Value
$81.73K
Shares Held After
205,141
% of Holdings
2.1%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
12,892
Price
$18.16
Total Value
$234.16K
Shares Held After
209,641
% of Holdings
5.8%
Showing 751–800 of 1119 transactions (page 16 of 23)